edoc

Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: a prospective cohort study in Lesotho (DO-REAL study)

Brow, J. A. and Nsakala, B. L. and Mokhele, K. and Rakuoane, I. and Muhairwe, J. and Urda, L.. (2022) Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: a prospective cohort study in Lesotho (DO-REAL study). HIV medicine, 23 (3). pp. 287-293.

[img] PDF - Published Version
Available under License CC BY (Attribution).

203Kb

Official URL: https://edoc.unibas.ch/91408/

Downloads: Statistics Overview


Faculties and Departments:09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Former Units within Swiss TPH > International HIV and chronic disease care (Labhardt)
UniBasel Contributors:Brown, Jennifer and Amstutz, Alain and Labhardt, Niklaus and Tschumi, Nadine
Item Type:Article, refereed
Article Subtype:Further Journal Contribution
ISSN:1464-2662
Note:Publication type according to Uni Basel Research Database: Journal item
Language:English
Identification Number:
edoc DOI:
Last Modified:29 Dec 2022 15:11
Deposited On:29 Dec 2022 15:11

Repository Staff Only: item control page